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Abstract
Interactions between protein aggregates and a cellular membrane have been strongly implicated in many protein
conformational diseases. However, such interactions for the case of Cu/Zn superoxide dismutase (SOD1) protein, which is
related to fatal neurodegenerative disorder amyotrophic lateral sclerosis (ALS), have not been explored yet. For the first
time, we report the direct observation of defect formation and increased ion permeability of a membrane induced by SOD1
aggregates using a supported lipid bilayer and membrane patches of human embryonic kidney cells as model membranes.
We observed that aggregated SOD1 significantly induced the formation of defects within lipid membranes and caused the
perturbation of membrane permeability, based on surface plasmon resonance spectroscopy, atomic force microscopy and
electrophysiology. In the case of apo SOD1 with an unfolded structure, we found that it bound to the lipid membrane
surface and slightly perturbed membrane permeability, compared to other folded proteins (holo SOD1 and bovine serum
albumin). The changes in membrane integrity and permeability were found to be strongly dependent on the type of
proteins and the amount of aggregates present. We expect that the findings presented herein will advance our
understanding of the pathway by which structurally disordered SOD1 aggregates exert toxicity in vivo.
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Introduction
Cu/Zn-superoxide dismutase (SOD1) is a ubiquitous enzyme
and has been linked to amyotrophic lateral sclerosis (ALS), also
known as Lou Gehrig’s disease [1,2,3]. Details of the mechanism
leading to the development of neurodegeneration in ALS are
currently unclear, but aberrant SOD1 aggregate formation has
been strongly implicated as a causative factor in the disease. A
number of pathogenic mechanisms have been proposed for the
relationship between ALS and SOD1 aggregates, including the
disruption of axonal transport [4], the aberrant binding of
apoptosis regulators [5], inhibition of the proteasome [6],
perturbations in mitochondrial function [7]. In these mechanisms,
interactions between the cellular membrane and the aggregate
have been somewhat overlooked, but are now thought to be a
factor in other protein-aggregation disease mechanisms [8]. The
disease relevance of protein-membrane interactions can be
elucidated with investigating the membrane interactions of the
protein aggregates to travel intercellularly [9,10] and the toxic
actions executed at the mitochondrial level through voltage-
dependent anion channel [11,12]. Therefore, a better understand-
ing of how SOD1 aggregate interacts with a membrane and what
is the nature of the consequences of such interactions might
provide a mechanism that compliments the existing thinking on
this subject.
Moreover, the hypothesis that SOD1 variants might aggregate
on mitochondrial membrane surfaces has recently been supported
by the demonstration that SOD1 aggregates are attached to the
cytoplasmic face of the mitochondrial membrane in transgenic
ALS mice [13,14,15]. Considering the ubiquitous distribution of
SOD1 in a cell (i.e. cytosol, nucleus, peroxisomes, lysosomes, and
mitochondrial intermembrane space), it would not be surprising
that SOD1 species would eventually interact with cell membranes,
as shown in the scheme in Figure 1A. However, in vivo monitoring
of protein-aggregation-associated pathogenic events is a difficult
task. Therefore, in vitro observation of cell membrane behaviors
changed by a specific type of protein, which differs from that of
other normal proteins, represents a meaningful approach to
understand the membrane components (i.e. lipid molecules)-
mediated cytotoxic actions generated in vivo.
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28982We herein, for the first time, report on such membrane-protein
aggregate interactions by investigating SOD1 aggregate-induced
changes in both the morphology of a supported lipid bilayer (SLB)
(Figure 1B) and the ion permeability of a cellular membrane
(Figure 1C). Significant morphological changes of the SLB in
terms of shape and surface coverage after exposure to SOD1
aggregates were characterized by the surface plasmon resonance
(SPR) spectroscopy [16] and atomic force microscopy (AFM) [17],
both of which are surface sensitive label-free techniques. Since
membrane damage could constitute a viable candidate for
membrane permeabilization [18,19,20], by measuring the current
changes in membrane patches detached from human embryonic
kidney (HEK 293) cells, we also observed unregulated membrane
permeabilization induced by aggregate-membrane interactions.
Results
Abnormal properties of structurally disordered SOD1
Since the disordered regions and/or monomerization [21,22,23]
as the result of the metal-free state of SOD1 have a role in initiating
protein aggregation, it is well known that apo SOD1 species (non
metal bound, usually exists as a monomer state) readily assemble to
largely aggregated structures under destabilizing conditions [21,
22,23,24,25,26], as shown in the description of Figure 2A.
Moreover, many recent publications [24,27] have presented
compelling evidence that wild-type (WT) and mutant SOD1 (i.e.,
especially their apo forms) share an aberrant conformation and a
common pathogenic pathway in ALS. In most cases, some of holo
mutants largely retain the stability of holo WT SOD1, which is an
exceptionally stable form. Related with this, it has been reported
that some of the holo mutant SOD1s actually are more stable than
apo WT SOD1 [24]. In addition, recent report presenting that the
overexpression of WT SOD1 accelerates disease onset of a G85R
SOD1 mouse [28], supports the pathogenic mechanism involved
with WT SOD1 in ALS. For this reason, we have first studied with
aggregates, prepared from apo WT SOD1 as a starting material, to
explore the in vitro membrane behavior related with SOD1
aggregates. The in vitro formation of an SOD1 aggregate was
achieved using apo WT SOD1 following a previously reported
protocol based on a treatment with 2,2,2-trifluoroethanaol (TFE)
[26]. TFE has been extensively used to study the structural
variations of other proteins [29,30]. An inset of Figure 2A shows the
general morphology of the as-prepared SOD1 aggregates. The
morphological properties of the aggregates prepared in vitro, were
also characterized by AFM imaging (Figure S1). The sizes and the
appearance of amorphous granular structures and rough surfaces,
were similar to those reported for ALS patients [31,32] and ALS
transgenic mice [26,33,34]. The circular dichroism (CD) spectrum
(Figure 2B) of apo WT SOD1 shows the characteristic b-sheet
pattern, with a broader peak than that for holo WT SOD1, due to
the structural change caused by the absence of Cu and Zn
2+, which
have both catalytic and structural roles in SOD1 [35]. Note that the
secondary structure of holo WT SOD1 is known to be mainly
comprisedof60%b-sheetand 30%randomcoilwiththeremainder
being an a-helix [36,37], compared to bovine serum albumin (BSA,
a negative control, mainly composed of a-helixes). In the case of the
SOD1 aggregate, the characteristic signature for secondary
structures was not found. Since these conformational changes in
Figure 1. Experimental approaches for understanding the interaction between SOD1 aggregates and cellular membranes. (A) A
cartoons showing the protein’s aggregation and its interaction with a cellular membrane. (B) The SPR instrumental setup equipped with a flow cell
used in an in vitro observation with an artificial SLB. (C) The inside-out configuration of the patch clamp used in an observation with a real cell
membrane patch.
doi:10.1371/journal.pone.0028982.g001
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changes in surface residues [2,38], ANS fluorescence was next
applied to determine how the surface property of the proteins are
altered during the aggregation. A higher ANS fluorescence (5.5-fold
enhancement, Figure 2C) was observed for the SOD1 aggregate,
compared to its native state (holo WT SOD1). This is caused by the
exposure the numerous hydrophobic residues on the protein surface
during the aggregation process. Native proteins (holo WT SOD1
and BSA) did not show significant ANS fluorescence enhancement
from the base line for a control sample (ANS dye only), while
substantial ANS fluorescence enhancement (2.5-fold) for the apo
WT SOD1 was observed. Based on our previous report [22], the
change in hydrophobicity of a protein significantly affects on the
interaction with lipid molecules, which are main components of the
cell membrane.
Monitoring of interactions between the SOD1 proteins
and SLB
Having shown that SOD1 aggregates have abnormal properties
(i.e., structural disorderness and hydrophobicity) compared to their
native state, we explored the interactions between the cellular
membrane and the SOD1 aggregates, using the methods described
in Figure 1B and 1C. We first used a supported lipid bilayer (SLB)
prepared from phospholipids (1,2-dipalmitoyl-sn-glycero-3-phos-
phocholine, DPPC, saturated lipid molecule). An SPR instrument
equipped with a reaction cell was used to monitor the interaction
between the SLB and the proteins in real-time. A flow cell was
mounted onto the SLB/Au/prism assembly so that protein
solutions could be easily introduced and flow across the SLB.
Interestingly, exposure to the SOD1 aggregate resulted in a
decrease in SPR reflectance (Figure 3A and Figure S2A), whereas
an increase due to the adsorption to SLB was observed for both apo
WT SOD1 and BSA (Figure 3B and 3C). The decrease or increase
in SPR reflectance can be attributed to changes in the mass of the
SLBs adjacent to the gold film, which is induced by interactions
between SLBs and proteins. When the SOD1 aggregates were
exposed to the cholesterol contained DPPC SLB, the decrease in
SPR reflectance was also observed (Figure S2B).
These interactions were also checked by the detection of
aggregates induced by the interactions between DPPC vesicles and
proteins. After incubating the proteins with DPPC vesicles, they
were sampled and then subjected to thioflavin T (ThT)
fluorescence measurements. ThT is a fluorescence probe used to
detect the presence of aggregates and the amount of aggregated
proteins [26], compared to the initial state of each sample.
Figure 4A shows the results for the time-resolved analysis for the
further SOD1 aggregation induced by the interaction between
proteins and lipid vesicles. As controls, we also analyzed the
proteins incubated without lipid vesicles (Figure 4B). No significant
changes were observed in the control cases. While, SOD1
aggregates, when incubated with lipid vesicles, demonstrated a
higher tendency to undergo aggregation than the other samples
depending on the incubation time. In the case of apo WT SOD1,
the fluorescence intensity also increased to a considerable extent.
This indicates that lipid-SOD1 complex [22] can be formed on a
SLB. Accordingly, the decrease (Figure 3A) or increase (Figure 3B
and 3C) in SPR reflectance can be attributed to the detachment of
lipid molecules on the SLB and binding to the SLB, respectively,
which are induced by interactions between SLBs and proteins. To
demonstrate the relevance of the observed strong binding affinity
of the SOD1 aggregates to the saturated DPPC lipid molecules, we
also examined the binding propensity with other lipid vesicles
Figure 2. Schematic illustration of SOD1 aggregation and its characteristics. (A) A scheme for the aggregation of SOD1. Inset is a shape of
as-prepared SOD1 aggregate. Bars, 200 nm. (B) CD spectra and (C) ANS fluorescence intensities for proteins (Red, SOD1 aggregates; orange, apo WT
SOD1; blue, holo WT SOD1; grey, BSA).; All protein samples were prepared in PBS at a concentration of 0.1 mg/mL. SOD1 aggregates were taken after
incubation with TFE for 5 days, and then characterized.
doi:10.1371/journal.pone.0028982.g002
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and cholesterol molecules). In the case of 1-palmitoyl-2-oleoyl-
phosphatidylcholine (POPC, unsaturated lipid molecule) lipid
vesicles (Figure S3), the insertion of cholesterol molecules to the
vesicles induced the significant increase of the fluorescent intensity
compared to the cases of POPC lipid only and cholesterol only.
The association propensity was also different among different mole
fraction between lipid molecules and cholesterol molecules (i.e.,
1:0, 1:1, 2:1, and 0:1). This result indicates that the interactions
between lipid vesicles and SOD1 aggregates can behave differently
dependent on the saturation of lipid molecule chain and the
composition of vesicles.
AFM images of the SLB surface were also obtained to visualize
and cross-check the results of the SPR measurements (Figure 3) for
changes in SLB and the ThT assay (Figure 4) for resulting
aggregates induced by molecular interactions between proteins
and lipid vesicles. Figure 5A shows an AFM image of the original
SLB surface formed on a gold substrate, which resembled the
morphology of the gold substrate (Figure S4). It should be noted
that the roughness of a gold surface was below 2 nm and that of
undamaged SLB surface was also below 2 nm. After the exposure
of SLB to SOD1 aggregates, numerous defects within the SLB
were observed (Figure 5B), compared with the SLB before
exposure (Figure 5A). In the case of apo WT SOD1, an AFM
image (Figure 5C) shows a considerable increase in the number of
clusters on the original smooth SLB surface, which is due to the
formation of a lipid-protein complex, as supported by the ThT
fluorescence measurement of the interaction between apo WT
SOD1 and lipid molecules (Figure 4A). Conversely, native BSA
was bound to the SLB and its integrity was maintained (Figure 5D),
which is attributable to its non-specific binding property and poor
aggregation propensity after incubation with lipid molecules, as
confirmed by the ThT assay (Figure 4A). From the results, we
conclude that the SOD1 variants with disordered regions, as the
Figure 3. SPR reflectance changes after the interactions between the proteins and the SLBs. (A) SPR reflectance decreases after the
interaction between SOD1 aggregates and SLB. (B) SPR reflectance increases after the interaction between apo WT SOD1 and SLB. (C) SPR reflectance
increases after the interaction between BSA and SLB. All proteins were prepared in PBS at a concentration of 0.1 mg/ml and were exposed to the lipid
membrane for 1 h. The time-resolved reflectance changes derived by the interaction between SLBs and injected proteins were measured using the
fixed angle method.
doi:10.1371/journal.pone.0028982.g003
Figure 4. Time-resolved ThT fluorescence measurement for the incubated proteins. (A) With DPPC lipid vesicles. (B) Without DPPC lipid
vesicles. To investigate the effect of the interaction of lipid molecules with proteins on aggregation, proteins were incubated with DPPC vesicles in
PBS at 37.5uC. As controls, proteins without DPPC vesicles were also incubated under the same conditions. All samples were incubated without
agitation. At each time point, an aliquot of each sample was taken and the presence of aggregates was determined using ThT fluorescence assay.
doi:10.1371/journal.pone.0028982.g004
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(SOD1 aggregate), can cause the loss of SLB integrity, as the result
of further aggregation on a SLB and/or the detachment of parts of
the SLB (i.e., defects), respectively.
Identification of defects within the SLB by interaction
with the SOD1 aggregate
We next performed an in-depth characterization of SLBs that
contained numerous defects. Figure 6A shows a line profile of the
resulting SLB (Figure 5B), caused by contact with SOD1
aggregates. The data show a remarkable height difference between
the bright domain and the dark domain of less than 8 nm
(indicated by red arrow-heads). Considering that the length of a
DPPC molecule is 3.4 nm [39], the bright and dark domains
correspond to remaining lipid layers and lipid-detached regions,
respectively. As shown in the right image of Figure 6A, the
remaining lipid layers (shown in pink) occupy approximately 20%
of the entire surface. This is in good agreement with the SPR
result, in which the loss of surface coverage by SLB was calculated
to be 80% (Figure 6B, Since SPR angular shift is typically
proportional to the surface coverage [40], we calculated the
change in coverage from the collected SPR angles for the SLB
before and after its contact with the SOD1 aggregates, which were
1.24u and 1.01u, respectively. We also observed the similar
decrease in the surface coverage of cholesterol contained DPPC
SLB after exposure to the SOD1 aggregates (Figure S2B, S2C).
This result clearly indicates that the changes in lipid membrane
integrity by interacting with the SOD1 aggregates are common
behaviors irrespective of the existence of cholesterol molecules. In
addition, we characterized the size of the defects based on the
AFM characterization for the SLB after its exposure to the SOD1
aggregates. As shown in Figure S5, we can obtain the statistic data
from the surface topography (Figure 6A) of the resulting lipid
membrane. Figure S5B shows the grains indicating the dark areas
(i.e., lipid detached areas) of the Figure S5A. Histograms (Figure
S5C, S5D) show the statistic distribution of the length and area of
the numbered areas in the Figure S5B, respectively. Result shows
that the majority of the defects have several hundreds of lengths
and areas of below 0.1 mm
2.
ThT fluorescence imaging (Figure 6C) was applied to SLB, to
determine whether or not the aggregate remains on the surface of
the SLB after the interaction. The inset shows a clear blue ThT
fluorescence for the SOD1 aggregate solution exposed to the SLB
layer, however, visible blue spots were not found over most of the
field of view for the resulting SLB, indicating that no aggregate
remains on the surface of the SLB. This further indicates that,
after the interaction between an aggregate and SLB, the aggregate
assembled with lipid molecules is detached from the SLB, thus
creating numerous defects within the SLB, as shown in the
description of Figure 6D.
Identification of unregulated membrane permeability in
HEK 293 cell membrane patches by SOD1 aggregates
It should be noted that the formation of defects within a
membrane by proteins is extremely important because the
perturbation in mass transport (i.e., membrane permeability by
Figure 5. AFM images of resulting SLB surfaces. (A) Original SLB layer. (B), (C), and (D) SLB layers after the interaction with SOD1 aggregates,
apo SOD1, and BSA, respectively. Bars, 1 mm. All images were obtained after the SPR measurement.
doi:10.1371/journal.pone.0028982.g005
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cytotoxicity [18,41]. Our finding of the formation of defects is also
supported by recent reports of membrane disruption by Amyloid-b
fibrils [18,20] and amyloidogenic human amylin peptide [19,41].
Although the changes in membrane integrity could constitute a
viable candidate for membrane permeabilization, membrane
permeabilization induced by protein aggregates has been mainly
investigated so far by indirect demonstrations, such as monitoring
the kinetics of a fluorescent probe released from vesicles [18,19]
and molecular simulations with proteins and vesicles [20]. By
monitoring the fluorescent dye released from the DPPC lipid
vesicles, we pre-observed the permeability of lipid membrane
(Figure S6). For a more practical demonstration, we examined
what occurs in a real cell membrane system, as the result of
changes in membrane integrity by the formation of defects and the
binding to cell membranes observed in our model system, SLB.
For a direct demonstration of membrane permeability with a
cellular membrane, we investigated membrane permeability by
measuring current changes in membrane patches detached from
HEK 293 cells upon exposure to different SOD1 variants.
In this test, to collect more biologically relevant information (i.e.
mutation effect) through the use of a real cell membrane patch,
A4V SOD1 as well as WT SOD1 was chosen for the following
reasons; (1) We suspected that membrane permeability might be
strongly dependent on the extent of aggregation, and it is well
known that the kinetics of aggregation for A4V are faster than that
of WT SOD1 [42,43]. (2) The A4V mutation is one of several
ALS-linked SOD1 mutations. As shown in Figure S7A, S7B, the
A4V SOD1 aggregate forms a much greater extent than that of
WT SOD1 under the same conditions due to the difference in
aggregation kinetics, which is consistent with previous reports
[21,42,43]. However, they share common properties of aggregates
in terms of surface property and morphology, as judged from the
ANS fluorescence enhancement (Figure S7C) and the electron
micrographs (Figure S7D). For as-prepared SOD1 variants, the
ionic permeability of HEK 293 cell membranes (Figure 7) was
measured using the inside-out configuration (a description of
Figure 1C) of a patch clamp. A large increase in conductance was
observed on perfusing the A4V SOD1 aggregate into the
experimental bath (Figure 7E). In stark contrast, no significant
change in conductance was observed in the control with BSA
(Figure 7A), which can be attributed to the conservation of the
integrity of membrane after being in contact with BSA, as
observed in the SLB (Figure 5D). For holo SOD1, no obvious
Figure 6. The formation of defects within the SLB by the interaction between the SOD1 aggregate and the SLB. (A) (p) and (h) AFM
image and height profile of the resulting SLB surface after the exposure to the SOD1 aggregate. (r) and (s) AFM image colored for remaining lipid
layers (shown in pink) and height distribution of entire surface. Remaining lipid layers occupy approximately 20% of the entire surface. (B) SPR
contour plots at each event. Each plot indicates before formation of SLB (black), after formation of SLB (blue), and after interaction between SLB and
SOD1 aggregates (red), respectively. (C) ThT fluorescence image of the resulting SLB surface. (An inset shows clear blue ThT fluorescence for a SOD1
aggregate solution.). Bars, 100 mm. (D) Description of the formation of defects within a SLB by the SOD1 aggregate.
doi:10.1371/journal.pone.0028982.g006
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SOD1 and A4V apo SOD1 (Figure 7B and 7D) slightly changed
conductance, which might be due to membrane binding and
further aggregation with lipid molecules induced by their
structural disorderness, based on the results observed for SLB
(Figure 5C). The WT SOD1 aggregate often increased the
membrane conductance (Figure 7C) but with far less frequency
than the A4V SOD1 aggregate (Figure 7E). Since such changes in
conductance are closely related to unregulated membrane
permeability, it appears likely that the SOD1 aggregates induce
the formation of numerous defects within the cellular membrane,
thus perturb membrane permeability. As expected, the changes in
extent of the conductance were correlated with the amount of
aggregates present, as confirmed by ThT fluorescence intensity
data (each inset of Figure 7). Taken together, different conforma-
tions at the metal-free state did not induce significant difference in
conductance changes (Figure 7B and 7D). However, when they
form aggregates, remarkable difference was observed according to
its original conformation (Figure 7C and 7E). On the basis of these
results, we can address that membrane permeabilization is more
strongly related with the quantity of resulting aggregates rather
than original conformations at their native and/or monomer
states. This can be supported by the recent reports showing that
WT and mutant SOD1 share an aberrant conformation and a
common pathogenic pathway in ALS [24,27].
Discussion
We note that interactions between protein aggregates and cell
membranes may play a crucial role in determining the
membrane-associated cytotoxicity of aggregated proteins, because
many protein conformation diseases (i.e., Alzheimer’s disease,
Parkinson’s disease, prion disease, and ALS) are known to be
related to membrane system [7,18,20,44,45,46]. In this study, we
for the first time demonstrate the cytotoxic actions of SOD1
aggregates associated with membranes by showing their abnor-
mality in terms of structural and surface properties, and by
investigating changes in the membrane integrity and permeabil-
ity. Based on our observations, it appears that the aggregates with
abundant hydrophobic parts, induced by conformational chang-
es, can be readily inserted to the inner space of the membrane
and assembled with the hydrophobic tails of lipid molecules. This
is well supported by our previous work [22] showing that the
change in hydrophobicity of a protein significantly affects on the
interaction with lipid molecules and finally induces the formation
of cytotoxic aggregation. Although the binding interactions
between the SOD1 aggregates and lipid membranes are affected
by various factors including lipid structures and lipid composi-
tions, the changes in the lipid membrane integrity by interacting
with SOD1 aggregates were found to be common behaviors. As a
result, defects within a membrane are formed by the detachment
Figure 7. The unregulated membrane permeability in HEK 293 cell membrane patches by the SOD1 aggregates. The ionic
permeability of HEK 293 cell membranes in response to the perfusion of proteins was measured at 10 kHz in inside-out configuration (Fig. 1C) of a
patch clamp. The bath (approximately 0.15 ml) was superfused at 1 ml/min and voltage clamp experiments were performed at room temperature
(22–25uC). (A–E) Electrophysiological recordings for (A) BSA, as a control, (B) Apo WT SOD1, (C) WT SOD1 aggregate, (D) Apo A4V SOD1, and (E) A4V
SOD1 aggregate. Bar graphs represent the ThT fluorescence intensity of each sample solution obtained before perfusing.
doi:10.1371/journal.pone.0028982.g007
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This in vitro observation was also directly examined by using real
cell membrane patches with more complicated compositions and
structures than artificial SLBs. Basically, the extent of changes in
permeability through membrane patches depended on the
amount of aggregates.
In conclusion, our findings suggest that a plausible explanation
for the changes in membrane integrity and permeability is the
structural disorderness and surface hydrophobicity of SOD1
aggregates, which are induced by conformational changes. That
is, the abnormal interaction between a membrane and SOD1
aggregates induces defects in membrane integrity, and perturbs
membrane permeability. We expect that this finding will advance
our understanding of the pathway by performing further through
investigations of the gain of toxic function of SOD1 variants and
offer diagnostics and therapeutics associated with ALS. To more
clearly address our observations, more investigations on other
structurally disordered proteins (i.e., Amyloid-b fibrils) as well as
other mutant SOD1s are currently underway by employing in
vitro observation methods used here. We believe that these
fundamental studies of biomolecular interactions can be a model
system and provide clues for understanding the intra- and
extracellular interactions between real cell membranes and
proteins.
Materials and Methods
Materials
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1-palmi-
toyl-2-oleoyl-phosphatidylcholine (POPC), bovine serum albumin
(BSA), and thioflavin T (ThT) were purchased from Sigma. 2,2,2-
trifluoroethanaol (TFE) was purchased from Aldrich. 11-mercap-
toundecanoic acid (MUA) and 8-anilino-1-naphthalene-sulfonic
acid (ANS) were obtained from Sigma-Aldrich. Standard 106
phosphate buffered saline (100 mM PBS), which contained the
salts; NaCl 80.0 g (1.37 M), KCl 2.0 g (27 mM), Na2HPO4 14.4 g
(100 mM), KH2PO4 2.4 g (17.6 mM), was diluted to the 25 mM
PBS for our all experiments. All chemicals were used as received
without further purification.
In vitro preparation of SOD1 aggregate
The purification of SOD1 proteins was achieved by following a
previously reported purification protocol [16,22]. To prepare
SOD1 aggregate, the purified apo SOD1 samples were diluted
with an acidic phosphate buffer saline (PBS) solution (pH 5.4) at a
concentration of 0.1 mg/ml [26]. SOD1 aggregates were
prepared by treatment with a solution containing 20% (v/v)
TFE. To monitor aggregate formation, ThT fluorescence of
samples was measured by fluorescence spectroscopy (LS 55,
PerkinElmer). ThT is known to associate rapidly with aggregated
fibrils, giving rise to a new excitation maximum at around 450 nm
and an enhanced emission at around 482 nm. 150 mL of each
sample was mixed with 15 mL of 10 mM ThT in PBS, and
fluorescence emission intensity was immediately and repeatedly
recorded at least five times to obtain a reasonable values. To
further characterize the morphology of the SOD1 aggregates,
transmission electron microscopy (TEM) was used. Samples
(150 mL aliquots) were incubated on 400-mesh carbon-coated
formvar copper grids overnight. The grids were air-dried and
stained with 1% (w/v) uranyl acetate. Specimens were viewed with
an energy-filtering TEM (LIBRA, Carl Zeiss) at an accelerating
voltage of 120 kV.
Circular dichroism (CD) spectroscopy
The secondary structure of proteins was determined by CD
analysis (Jasco J-715 spectropolarimeter). A 0.1-cm quartz cell was
used for the measurements and the CD spectra were recorded from
190 to 250 nm. All CD measurements were carried out using the
following parameters: 1 nm bandwidth, 50 nm/min run speed,
1 nm step size, 8.3 s response time, and an average of three runs.
ANS fluorescence spectroscopy
For the measurement of surface hydrophobicity, the fluores-
cence property of the extrinsic fluorophore ANS (final concentra-
tion 20 mM, excitation at 360 nm, bandwidth 5 nm) was
examined by 10 min of incubation at 37uC with proteins in the
buffer via fluorescence spectroscopy.
Preparation of lipid vesicles and SLBs
The vesicles were prepared by probe sonication. A 40 mg
portion of lipids was dissolved and agitated in 4 mL chloroform in
a glass vial. For the preparation of cholesterol contained lipid
vesicles, cholesterol molecules were added to the lipid solution by
the desired molar ratios. Freeze-and-thaw cycles by liquid nitrogen
for three times. The organic solvent was evaporated with a
nitrogen stream to form a thin lipid layer on the inner wall of the
vial. Dried lipid films were resuspended in PBS at a concentration
of 0.1 mg/mL, and the suspension was sonicated at low amplitude
in an ice bath for 30 min. Sonication for 5–10 min was repeated to
avoid too much increase in the suspension temperature. The
resulting vesicle solution was then stored at 4uC before use. For the
preparation of SLBs, Au substrate was modified by pretreatment
of 5 mM MUA ethanolic solution for overnight and was rinsed
with pure ethanol to remove the excess molecules. The resulting
hydrophilic substrate was incubated under 100 mL of the vesicle
suspension for 2 h at 45uC. After incubation, the excess vesicles
were removed by rinsing with PBS.
In situ SPR/SLB assays and AFM imaging
For the real-time analysis of interaction between SLBs and
proteins, commercial SPR instrumentation (K-MAC) equipped
with reaction cell was used [16]. Specimens of SOD1 aggregates,
apo SOD1, and native BSA were separately dispersed in PBS at a
concentration of 0.1 mg/ml. Each specimen was exposed to the
lipid membrane for 1 h. The time-resolved reflectance changes
derived by the interaction between SLBs and injected samples
were measured using the fixed angle method. The change in
surface coverage of the remained SLB was calculated from the
collected SPR angles, since SPR angular shift is typically
proportional to the surface coverage [40]. After the incubation
with each protein solution, the resulting morphologies of SLBs
were also characterized by AFM imaging. AFM images were
acquired in non-contact mode using an atomic force microscope
(XE-100, Park systems). Uncoated silicon cantilevers with typical
tip curvature radius of about 10 nm were used.
Time-resolved analysis of lipid molecule-induced
aggregation
To investigate the effect of the interaction of lipid molecules
with proteins on aggregation, proteins were incubated with DPPC
vesicles in PBS at 37.5uC. As controls, proteins without DPPC
vesicles were also incubated under the same conditions. All
samples were incubated without agitation. At each time point, an
aliquot of each sample was taken and the presence of aggregates
was determined using ThT fluorescence assay.
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Human embryonic kidney (HEK 293) cell line was obtained
from American Type Culture Collection (Manassas, VA, USA).
Prior to the experiment, HEK 293 cells were grown in Dulvecco’s
Modified Eagle’s Medium (DMEM) (Invitrogen) supplemented
with 10% (v/v) heat-inactivated fetal bovine serum (Hyclone,
Logan, UT), (Sigma), and 1% penicillin/streptomycin (Invitrogen).
All cells were incubated in 20% O2, 10% CO2 37uC.
Electrophysiological recordings
For electrophysiological recordings, the cells were transferred
into a bath mounted on the stage of an inverted microscope (IX-
70, Olympus). The bath (approximately 0.15 ml) was superfused
at 1 ml/min and voltage clamp experiments were performed at
room temperature (22–25uC). Patch pipettes with a free-tip
resistance of about 2.5 MV were connected to the head stage of
a patch-clamp amplifier (Axopatch-1D, Axon Instruments).
pCLAMP software v.9.2 and Digidata-1322A (both from Axon
Instruments) were used for the acquisition of data and the
application of command pulses. Single channel activities were
recorded at 10 kHz in inside-out configurations. The pipette
solution contained (in mM) 145 KCl, 1 EGTA, and 10 HEPES
with a pH of 7.4 (titrated with KOH). The bath solution contained
(in mM) 145 KCl, 1 EGTA, and 10 HEPES with a pH of 7.2
(titrated with KOH). The voltage and current data were low-pass
filtered at 1 kHz. Current traces were stored and analyzed using
Clampfit v.9.2 and Origin v. 7.0 (Microcal Inc.).
Supporting Information
Figure S1 Morphology of the prepared SOD1 aggre-
gates. (A) AFM image of the SOD1 aggregates formed after 5
days incubation. Bar, 5 mm. (B) Three-dimensional image of (A)
showing amorphous granular structures and rough surfaces. (C)
Thickness profile of a red line in (B).
(TIF)
Figure S2 SPR contour plots for SLBs disruption
process according to the regular time-interval exposure
of SOD1 aggregates. (A) Interaction between SOD1 aggregates
and DPPC lipid layer (B) Interaction between SOD1 aggregates
and DPPC lipid layer with cholesterol domains. (C) Plots for the
coverage of SLBs remained according to the interaction time with
SOD1 aggregates.
(TIF)
Figure S3 The interactions between the lipid vesicles
and SOD1 aggregates for four types of lipid vesicles with
different compositions.
(TIF)
Figure S4 Formation of a SLB on a Au substrate. (A) SPR
contour plots before and after formation of SLB on the hydrophilic
Au surface. (B) AFM images of a hydrophilic Au surface modified
with MUA (left) and a SLB surface formed after vesicle fusion
(right). Bars, 500 nm.
(TIF)
Figure S5 The size and distribution of the defects within
lipid membrane based on the AFM characterization. (A)
Surface topography of the resulting lipid membrane after
interaction with the SOD1 aggregates. (B) Image assigning the
grains where indicate the dark areas (i.e., lipid detached areas) of
the Figure S5A. (C) and (D) Statistic distribution of the length and
area of the numbered areas in the Figure S5B.; The majority of the
defects have several hundreds of lengths and areas of below
0.1 mm
2.
(TIF)
Figure S6 Dye leakage assay from the lipid vesicles
induced by interactions between the lipid vesicles and
SOD1 aggregates.
(TIF)
Figure S7 The A4V and WT SOD1 aggregates used in
this study share a common morphology, but the kinetics
of their aggregation is dramatically different. (A) ThT
florescent intensity of the prepared SOD1 aggregates under same
conditions (i.e., same protein concentration and destabilizing
condition). (B) Visualization of the aggregates by formation of the
precipitation, which are induced by gold nanoparticle binding to
the SOD1 aggregates; The A4V aggregate is much more formed
that of WT SOD1 under the same conditions (Note that the
aggregation kinetic of A4V is faster than that of WT.). (C) and (D)
ANS fluorescence enhancement and morphologies of prepared
aggregates show the similarity between WT (left) and A4V (right).
(TIF)
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